Chemotherapy for Locoregionally Advanced NPC
Author:
Publisher
Springer Berlin Heidelberg
Link
https://link.springer.com/content/pdf/10.1007/174_2023_466
Reference133 articles.
1. Abu Eid R, Razavi GS, Mkrtichyan M, Janik J, Khleif SN (2016) Old-school chemotherapy in immunotherapeutic combination in cancer, a low-cost drug repurposed. Cancer Immunol Res 4(5):377–382
2. Ahn YC, Kim YS (2016) Korean perspectives of nasopharynx cancer management. Chin Clin Oncol 5(2):28
3. Al-Kourainy K, Crissman J, Ensley J, Kish J, Kelly J, Al-Sarraf M (1988) Excellent response to cis-platinum-based chemotherapy in patients with recurrent or previously untreated advanced nasopharyngeal carcinoma. Am J Clin Oncol 11(4):427–430
4. Allen SG, Rosen BS, Aryal MP, Cao T, Schipper M, Casperet K et al (2022) Early toxicity and patient reported outcomes from a phase 2 trial of FDG-PET response-based De-Escalated definitive radiotherapy for p16+ oropharynx cancer. Int J Radiat Oncol Biol Phys 112(5):e3
5. Al-Sarraf M, Pajak TF, Cooper JS, Mohiuddin M, Herskovic A, Ager PJ (1990) Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: a radiation therapy oncology group study. J Clin Oncol 8(8):1342–1351
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3